chr11-110247798-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_002906.4(RDX):āc.995T>Cā(p.Ile332Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,590,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002906.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RDX | NM_002906.4 | c.995T>C | p.Ile332Thr | missense_variant | 10/14 | ENST00000645495.2 | NP_002897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RDX | ENST00000645495.2 | c.995T>C | p.Ile332Thr | missense_variant | 10/14 | NM_002906.4 | ENSP00000496503.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151850Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000210 AC: 45AN: 214444Hom.: 1 AF XY: 0.000294 AC XY: 34AN XY: 115714
GnomAD4 exome AF: 0.000112 AC: 161AN: 1438754Hom.: 1 Cov.: 31 AF XY: 0.000150 AC XY: 107AN XY: 714178
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151966Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 20, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 08, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ile332Thr var iant in RDX has not been previously reported in individuals with hearing loss, b ut has been identified in 0.1% (17/11458) of South Asian chromosomes by the Exom e Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs53310716 4). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tool s and conservation analysis suggest that the p.Ile332Thr variant may not impact the protein, though this information is not predictive enough to rule out pathog enicity. In summary, while the clinical significance of the p.Ile332Thr variant is uncertain, its frequency in the general population and computational analyses suggest that it is more likely to be benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at